E2F transcription factors regulate proliferation, differentiation, DNA repair and apoptosis. Tight E2F regulation is crucial for epidermal formation and regeneration. However, virtually nothing is known about the molecular events modulating E2F during epidermal keratinocyte differentiation. Elucidation of these events is essential to understand epidermal morphogenesis, transformation and repair. Here we show that, in differentiating keratinocytes, Ca 2 þ -induced protein kinase C (PKC) activation downregulates E2F1 protein levels. Further, we have identified PKC d and g as those isoforms specifically involved in induction of E2F1 proteasomal degradation. We also demonstrate that E2F1 downregulation by novel PKC isozymes requires activation of p38b mitogenactivated protein kinase (MAPK). This is the first example of regulation in the E2F transcription factor family by activation of PKC and MAPK in the context of biologically significant differentiation stimuli in epithelia.
Introduction
The E2F family of transcription factors is a wellestablished regulator of many cell responses, such as cell cycle progression, differentiation, apoptosis and DNA repair (Cam and Dynlacht, 2003; Bell and Ryan, 2004) . However, a key issue that remains poorly understood is, how external stimuli that induce changes in proliferation or differentiation are transmitted intracellularly to regulate E2F. Further, although it has been established that E2F proteins can be regulated transcriptionally and post-translationally, the identification of the physiological stimuli governing such regulation is in its infancy.
E2F proteins are differentially modulated in epidermal keratinocytes. E2F1, -2 and -3 are abundant in undifferentiated keratinocytes. Differentiation triggers downregulation of these E2F forms and upregulation of E2F5 (D'Souza et al., 2001) . The biological importance of E2F1 function and regulation in epidermal homeostasis has been amply demonstrated. For example, E2F1 is essential to maintain normal proliferation in undifferentiated keratinocytes, and inactivation of the E2f1 gene in mice yields epidermal cells with doubling times about seven-fold longer than wild-type cells, and which exhibit severely reduced ability to re-epithelialize the skin during cutaneous regeneration . Conversely, E2F1 downregulation is necessary for proper keratinocyte differentiation, as exogenous E2F1 expression in differentiating cultured keratinocytes prevents exit from the cell cycle, causes apoptosis and interferes with expression of differentiation markers, such as transglutaminase 1 and keratin 10 (Dicker et al., 2000; D'Souza et al., 2001) . Further, abnormal E2F1 expression in the squamous epithelia of transgenic mice induces hyperproliferation, hyperplasia and apoptosis in vivo, both in interfollicular and follicular epidermis (Pierce et al., 1998 (Pierce et al., , 1999 .
In the epidermis, an extracellular Ca 2 þ gradient is present from the undifferentiated basal to the terminally differentiated cornified layer. Indeed, an important mechanism for keratinocyte induction of terminal differentiation involves Ca 2 þ signaling (reviewed in Koster and Roop, 2004) . In culture, primary mouse keratinocytes can be maintained as an undifferentiated cell population, and can be induced to differentiate by elevating the extracellular Ca 2 þ concentration to 0.1-2.0 mM (Dotto, 1999) . Calcium treatment of these cells activates protein kinase C (PKC), tyrosine kinases and phosphatidyl inositol-3 (PI-3) kinase, mimicking epidermal differentiation processes, including entry into quiescence and expression of differentiation markers. Central in keratinocyte withdrawal from the cell cycle is the E2F/pRb network (Ruiz et al., 2004) . However, several key issues remain to be resolved: What are the pathways that convey extracellular differentiation signals to downstream E2F proteins? To which extent do these pathways converge in the regulation of other differentiation targets? What are the mechanisms of E2F regulation in differentiating keratinocytes?
We have begun to address those questions, and demonstrate that Ca 2 þ -induced activation of PKC in differentiating keratinocytes results in E2F1 protein destabilization through mechanisms that also involve p38b activation. Together, these results point to PKC-and p38-mediated E2F1 turnover as a critical component of differentiation responses in epithelial cells.
Results
Protein kinase C activation modulates E2F in differentiating epidermal mouse keratinocytes In primary murine keratinocytes, induction of differentiation by culture in medium containing 1.0 mM Ca 2 þ leads to downregulation of E2F1, -2 and -3, upregulation of E2F5, and changes in DNA-binding complexes (D'Souza et al., 2001) . In agreement with previous reports (D 'Souza et al., 2001) , analysis of E2F DNAbinding complexes by electrophoretic mobility shift assays (EMSA) using lysates from undifferentiated keratinocytes cultured in 'low Ca 2 þ ' (0.05 mM) medium revealed the contribution of E2F1, pRb and p107, as evidenced by the formation of supershifted species in the presence of antibodies against those proteins ( Figure 1a ). In contrast, no changes in banding pattern were detected in the presence of antibodies against p130 or E2F5, indicating that these proteins may be minor constituents of E2F DNA-binding complexes in these cells (Figure 1a ). Induction of differentiation by culture in 'high Ca 2 þ ' (1.0 mM) medium resulted in the formation of complexes mainly composed of p107 and p130 ( Figure 1a ). E2F5-containing DNA binding species were also detected in differentiated keratinocytes ( Figure 1a) .
To identify the events activated by Ca 2 þ upstream from E2F, we first investigated the involvement of kinase signaling cascades known to be involved in primary keratinocyte differentiation in the formation of E2F/p130 and E2F/p107 complexes using EMSA. These signaling cascades include PKC, tyrosine kinases and phosphoinositide-3 kinase (Dotto, 1999) . Treatment of undifferentiated keratinocytes with the PKC activator 12-O-tetradecanoylphorbol-13-acetate (TPA) mimicked the Ca 2 þ -induced formation of E2F5-, p130-and p107-containing complexes (Figure 1b) . Conversely, treatment with the PKC inhibitors chelerythrine or Ro318220 interfered with the induction of those complexes by Ca 2 þ (Figure 1b) . In contrast, the presence of the tyrosine kinase inhibitors genistein and herbimycin, or the phosphoinositide-3 kinase inhibitor wortmannin did not interfere with Ca 2 þ -induction of the E2F/p107 and E2F/p130 DNA-binding species associated with differentiation ( Figure 1c) . Although TPA and the PKC inhibitors may individually modulate cellular pathways other than PKC, taken together, our results are consistent with the concept that PKC is involved in regulation of E2F DNA-binding complex formation in differentiating keratinocytes.
Activation of PKC by TPA also mimics the reduction in E2F1 and increase in E2F5 protein levels induced by Ca 2 þ in differentiated cells (Figure 2a ), but does not alter levels of E2F2 or E2F3 (Figure 2b ). Finally, the Ca 2 þ -induced E2F1 decrease was abolished in the presence of the PKC inhibitor Ro317549, further evidencing the involvement of PKC as an upstream E2F1 regulator (Figure 2c ). Importantly, it has been shown that long-term (>18 h) TPA treatment of keratinocytes does not result in downregulation of all PKC activity. Specifically, although these conditions result in downregulation of the a and e isoforms, PKC d, Z and z remain active (Reynold et al., 1994; Efimova et al., 1998) . Formation of differentiation-specific E2F DNA-binding complexes requires PKC activation. (a) Primary murine keratinocytes were isolated and cultured in low Ca 2 þ medium (0.05 mM) or high Ca 2 þ medium (1.0 mM) for 24 h. Keratinocyte lysates were prepared and DNA-binding reactions were conducted using an oligonucleotide probe containing the E2F element in the DHFR promoter. DNA-binding reactions were conducted in the presence of the indicated antibodies for 45 min prior to separation by nondenaturing gel electrophoresis. Supershifted bands in the presence of the antibodies are indicated with *. Undifferentiated cells cultured in low Ca 2 þ show multiple bands corresponding to 'free' E2F/DP complexes (F), and lower mobility complexes containing pRb and p107. (b) Keratinocytes were cultured for 24 h in high Ca 2 þ ( þ ) or low Ca 2 þ (À) medium in the presence of TPA (100 nM), chelerythrine (Chel, 1 mM), or Ro318220 (Ro, 1 mM), as indicated. E2F DNA-binding reactions were conducted in the presence of the indicated antibodies, and analyzed by EMSA. (c) The formation of p107 and p130 complexes in cells induced to differentiate by culture in medium containing 1.0 mM Ca 2 þ is not affected by the presence in culture media of the protein tyrosine kinase inhibitors herbimycin A (Herb, 1 mM) and genistein (Genis, 300 mM), or to the PI-3 kinase inhibitor wortmannin (Wort, 50 nM).
Post-transcriptional regulation of E2F1 by PKC in differentiating keratinocytes
We next focused on the mechanisms of E2F1 downregulation in response to PKC activation. First, we addressed the effect of TPA on E2F1 mRNA levels and found no significant differences between treated and untreated cells (data not shown). We also measured TPA-induced E2F1 protein decay by examining changes in E2F1 levels in cells treated with cycloheximide (CHX) (Figure 3a, b) . The half-life of E2F1 in the presence of CHX was about 11.5 h, and was reduced to about 6.5 h when TPA was also present (Figure 3c ), indicating that PKC activation increases E2F1 turnover in keratinocytes. Although the CHX treatment precludes measurement of E2F1 half-life in epidermal cells under normal growth conditions, these experiments indicate that PKC Primary keratinocytes cultured in medium containing 0.05 mM Ca 2 þ were treated with CHX 100 mg/ml 30 min prior to addition of TPA, used to induce differentiation (100 nM). Cell lysates were prepared at the indicated times following addition of TPA, resolved by SDS-PAGE and analyzed by immunoblotting with the indicated antibodies. (c) Densitometric quantification of E2F1 protein levels in keratinocytes treated with CHX or CHX þ TPA, as described above. Densitometric E2F1 vaues were normalized to g -tubulin.
The results are expressed as mean þ s.d. (n ¼ 3). * indicates Po0.01 (Student's t-test). (d) Keratinocyte cultures were incubated in high Ca 2 þ medium for 8 h prior to the addition of MG132. Cell lysates were prepared 16 h after MG132 treatment, and analysed by imunoblot, as described in (a).
activation is sufficient to increase E2F1 turnover, independent of de novo protein synthesis.
The retinoblastoma protein (pRb) can associate with and stabilize E2F1 (Hofmann et al., 1996) . Hence, we investigated if the decrease in E2F1 stability was associated with disappearance of pRb. We examined pRb levels as a function of time and found a moderate increase after 10 h of incubation in the presence of CHX. Incubation of cells in the presence of both CHX and TPA decreased pRb levels by about 50% after 10 h. pRB has been shown to be a substrate for PKC (Suzuma et al., 2002) , and increased pRb phosphorylation can decrease the stability of this protein (Pen˜uelas et al., 2003) . Whether PKC-induced phosphorylation of pRb caused the observed decreases in pRb levels remains to be established. Nevertheless, it is noteworthy that pRb is still highly expressed in TPA-treated keratinocytes at a time when 90% of E2F1 has already been degraded (Figure 3b ), suggesting the possibility that modifications in E2F1 and/or pRb may preclude the latter from protecting E2F1 from degradation. E2F1 turnover involves ubiquitination followed by proteasomal degradation (Hateboer et al., 1996; Campanero and Flemington, 1997) . To determine if Ca 2 þ -induced E2F1 degradation occurs through proteasomal activity, we treated differentiating keratinocyte cultures with high Ca 2 þ in the presence or absence of the proteasomal inhibitor MG132. The presence of MG132 in keratinocytes cultured abrogated E2F1 downregulation induced by high Ca 2 þ (Figure 3d ), indicating that differentiation triggers a cascade of cellular events that culminate in increased rates of proteasomal E2F1 degradation.
Activation of PKCd and PKCZ mediates E2F1 downregulation in differentiating keratinocytes
Five PKC isozymes are expressed in the epidermis (a, d, e, Z, z ) (Denning, 2004) . Of these, activation of the a, d and Z forms has been associated with various keratinocyte differentiation responses, including involucrin upregulation, activation of Fyn tyrosine kinase, and withdrawal from the cell cycle (Ohba et al., 1998; Cabodi et al., 2000; Alt et al., 2001; Eckert et al., 2004) . To identify the PKC form(s) involved in E2F1 regulation, we measured E2F1 levels in cells exogenously expressing each isozyme using recombinant adenoviruses, or a control b-gal-encoding virus (Figure 4a ). High levels of exogenously expressed PKC isoforms are sufficient to increase PKC activity substantially, even in the absence of TPA or other stimuli, in various cell types, including epidermal keratinocytes (Ohba et al., 1998; Li et al., 1999) . Exogenous expression of PKCd or Z, but not of a or e, induced a marked decrease in E2F1 protein levels 24 and 48 h after adenoviral infection (Figure 4b) , with no significant changes in E2F1 mRNA abundance (data not shown). Expression of PKC z inconsistently had small effects on E2F1 protein abundance.
To confirm that PKCd and Z are indeed upstream E2F1 regulators, we also expressed dominant-negative (dn) forms of these enzymes via recombinant adenoviruses (Figure 5a ). We then measured E2F1 levels in cells infected with adenoviruses encoding these PKC forms. We also used several adenoviruses as controls, including the nonrecombinant adenovirus MX17 (which is a control for the PKCd viruses), as well as an adenovirus encoding b-gal (which is a control for PKCZ and PKCe). We then treated all cultures with TPA, and observed that expression of either dn PKCd or Z, but not of b-gal or dn PKCe, abrogated TPA-induced E2F1-downregulation (Figure 5b ). These data suggest that Ca 2 þ treatment of keratinocytes triggers a differentiation signaling cascade that activates PKC d and Z, which, in turn, regulates E2F1 protein turnover.
p38 MAP kinase activation mediates E2F1 downregulation in differentiating keratinocytes
We next investigated the identity of PKC downstream effectors that mediate E2F1 turnover. In primary epidermal keratinocytes, PKCZ activates Fyn tyrosine kinase and decreases cyclin E/cdk2 (Cabodi et al., 2000; Kashiwagi et al., 2000) . In these cells, activation of PKCd results in sequential activation of ras, MEKK1, MEK3 and p38 (Eckert et al., 2004) . This pathway is very important for differentiation, as it promotes expression of the differentiation markers involucrin and transglutaminase 1 (Ohba et al., 1998; Cabodi Kashiwagi et al., 2000) . Given that tyrosine kinase inhibitors did not affect Ca 2 þ -induced changes in E2F DNA-binding complexes, we first turned our attention to the mitogen-activated protein kinase (MAPK) cascade and p38. Keratinocytes express p38 a, b and d (Dashti et al., 2001) . We reasoned that inhibition of p38 activity would abrogate PKC-induced E2F1 downregulation if p38 acts downstream of PKC. Thus, we expressed PKCd, and observed that E2F1 downregulation was abolished in the presence of the p38 inhibitors SB203580 or SB202190, but not in the presence of the inactive analogue SB202474 (Figure 6a ). We obtained similar results when we expressed PKCZ in the presence of those same drugs (Figure 6b ), whereas the inhibitors by themselves had no effect on E2F1 levels (Figure 6c ). At the concentrations used (10 mM), these p38 inhibitors are selective for p38a and p38b, and do not affect p38d (Kumar et al., 2003) . Hence, p38d plays little, if any, role in differentiation-induced E2F1 changes.
To determine whether p38a or p38b mediate E2F1 turnover, we infected TPA-treated keratinocytes with recombinant adenoviruses encoding dn p38 mutants. Expression of dn p38b, but not of dn p38a, interfered with the reduction in E2F1 protein levels induced by TPA (Figure 7) . Thus, we have defined a hitherto unidentified pathway in differentiating keratinocytes in which Ca 2 þ activates PKCd and PKCZ, which results in activation of p38b and increased E2F1 protein turnover. We also attempted to knockdown p38a and p38b using siRNA approaches. Although we observed a decrease in p38 mRNA, this did not translate into p38 protein loss even after several days of siRNA treatments (data not shown). However, the results we obtained by combining pharmacological and genetic approaches to inhibit p38 are consistent with the notion that this MAPK pathway is involved in E2F1 regulation in keratinocytes. Although the exact mechanism of p38b modulation of E2F1 remains to be elucidated, the activation of this pathway is crucial for normal epidermal morphogenesis and function, given that E2F1 is essential for epidermal keratinocyte proliferation and epidermal regeneration , and its downregulation is necessary for normal expression of differentiation 
Discussion
E2F transcription factors are fundamental regulators of cell cycle progression, differentiation, DNA repair and apoptosis. During epidermal development and keratinocyte differentiation, E2F forms are modulated at multiple levels, including mRNA and protein abundance, interactions with pRb family proteins and subcellular distribution (D'Souza et al., 2001; Apostolova et al., 2002) . E2F activity is essential for proper epidermal morphogenesis and keratinocyte proliferation, as evidenced by the perturbations in these processes caused by exogenous expression of a dn DP-1 mutant in primary cultured keratinocytes and embryonic ectodermal explants (Chang et al., 2004) . Further, E2F1 fulfills essential, nonredundant functions in epidermal keratinocytes. Inactivation of the E2f1 gene leads to reduced keratinocyte proliferation, migration and attachment to the extracellular matrix in culture, as well as impaired epidermal regeneration after injury in vivo .
In spite of the demonstrated importance of E2F1 in epidermal formation and homeostasis, a central question to be addressed is how differentiation signals are transmitted. We established that induction of differentiation in epidermal keratinocytes is a physiological stimulus that negatively modulates E2F1 protein stability. Second, we demonstrate a signaling pathway linking Ca 2 þ -induced keratinocyte differentiation with E2F1 regulation, which involves activation of PKCd and Z, and of p38b MAP kinase. Other differentiation responses, such as cell cycle exit and involucrin expression, are induced by those two PKC enzymes (Efimova et al., 1998; Ohba et al., 1998) , and PKCZ is indispensable for epidermal homeostasis in vivo (Chida et al., 2003) . The mechanistic relationship between activation of PKCd and Z remains to be defined. One possibility is that they modulate each other, similar to the regulation of PKCd by PKCa in lymphoma cells (Romanova et al., 1998) . Alternatively, these PKC isozymes may act on a common downstream target(s).
E2F1 protein abundance is partly determined by degradation via ubiquitin-dependent proteolysis and stabilization through association with pRb, which interferes with ubiquitination (Hateboer et al., 1996) . Importantly, E2F1 degradation in differentiating keratinocytes involves proteasomal activity, and occurs in spite of the continuous presence of pRb. Murine keratinocyte differentiation is associated with loss of E2F/pRb DNA-binding complexes (D'Souza et al., 2001) , and we have been unable to detect E2F1/pRb complexes in differentiated cells (IA Ivanova and L Dagnino, unpublished observations). The mechanisms that mediate PKC-induced dissociation of E2F1 from pRb remain to be elucidated. However, the inability of E2F1 to complex with pRb may contribute to its degradation.
Regions in E2F1 outside its pRb-interacting Cterminus can also regulate post-translational modifications and stability. For example, phosphorylation on S403 and T433 causes E2F1 degradation (Vandel and Kouzarides, 1999) . Notably, these two residues are within sequences that correspond to both cdk and MAPK consensus sites, and are phosphorylated by cdk7 and other, as yet unidentified, kinases. We have detected E2F1 in activated-p38 immunoprecipitates from differentiated keratinocytes (IA Ivanova and L Dagnino, unpublished observations), which leads us to speculate that p38 may modify E2F1, thus regulating its stability. The increased E2F1 turnover in keratinocytes contrasts with its stabilization during myogenic differentiation in C2/C12 myoblasts, which involves interactions with pRb (Martelli et al., 2001) . E2F1 downregulation may be a requisite for proper differentiation of various cell types, as exogenous E2F1 expression prevents terminal differentiation in chondrocytes (Scheijen et al., 2003) , preadipocytes (Porse et al., 2001) , and HaCat cells, a human keratinocyte cell line (Paramio et al., 2000) .
PKCd and Z are activated during Ca 2 þ -or TPAinduced keratinocyte differentiation, resulting in sequential activation of ras, MEKK1, MEK3 and p38 (Eckert et al., 2004) . This pathway promotes expression of the differentiation markers involucrin and transglutaminase 1 (Ohba et al., 1998; Cabodi et al., 2000; Kashiwagi et al., 2000) . In these cells, TPA treatment leads to p38 activation observed by 2 h. Maximum p38 activity is maintained between 6 and 24 h post-TPA (Efimova et al., 2002) . E2F1 levels begin to decrease 2-4 h after TPA treatment, and reach their minimum by 10 h. Importantly, the kinetics of E2F1 loss suggest that this event occurs just downstream from or in association with p38 activation. It is also noteworthy that, whereas transcriptional activation of the involucrin gene mainly involves p38d (Efimova et al., 2002) , E2F1 downregulation occurs through p38b. Although p38a and p38b are involved in differentiation of some cell types (Faigle et al., 2004; Qi et al., 2004) , this is, to our knowledge, the first report of inhibition E2F transcription factor stability by differentiation-induced activation of MAP kinases.
Various signaling events modulate the E2F/pRb growth regulatory network. A well-defined signaling cascade involves activation of phosphoinositide-3 kinase and Akt/PKB, which results in upregulation of Cyclin D, followed by pRb phosphorylation and release of E2F, indirectly activating its transcriptional activity (Brennan et al., 1997) . Our studies show a novel mechanism for E2F1 regulation via PKC-MAPK pathways during epidermal differentiation, thus adding additional layers of complexity to the pathways that modulate the E2F/pRb growth regulatory network.
Materials and methods

Reagents and antibodies
The antibodies and their sources were as follows: PKCa (610107), PKCd (610397) and PKCe (610397) from BD Transduction Laboratories; E2F5 (SC-999) from Santa Cruz Biotechnologies; E2F1 (MS880) from Neomarkers; AU1 (MMS-130R) from Covance; PKCz from BIOMOL; glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Cat. No, 4699-9555) from Biogenesis and g-tubulin (T6557) from Sigma. The p38 inhibitors SB203580, SB202190 and SB202474, MG132, and the PKC inhibitors Ro317549 and Ro318220 were from Calbiochem. All other reagents were from Sigma.
Adenoviruses
Recombinant adenovirus encoding wild type (wt) PKCa, wt and dn PKCdK 376R, and wt and dn PKCe (Carpenter et al., 2001; Cazzoli et al., 2002) were gifts of Dr T Biden. The PKCzencoding adenovirus was a gift from G King (Suzuma et al., 2002) . The dn PKCZ cDNA contains a K384A mutation (Ohba et al., 1998) , and was generated by polymerase chain reaction. Both PKCd K376R and PKCZ K384A mutants lack kinase activity and exhibit isozyme-specific dn properties (Ohba et al., 1998; Carpenter et al., 2001) . Plasmids encoding mouse dn p38a and human dn p38b cDNAs (Jiang et al., 1996; Engelman et al., 1998) were gifts, respectively, from P Scherer and J Han. Mutant PKCZ, p38a or p38b cDNA was cloned into pShuttleCMV (gift of B Vogelstein), which was used to generate recombinant adenoviruses using the Ad-Easy system (He et al., 1998) . The virus controls used to account for the two different adenoviral vector backbones were Ad-MX17 (for PKCa, and wt and dn PKCd) and Ad-LacZ, which encodes b-galactosidase (b-gal; control for PKCe, wt and dn PKCZ, PKCz, dn p38a and dn p38b). Adenoviruses were purified on CsCl gradients and titered prior to use.
Cell culture
Primary keratinocytes isolated from 1-2-day-old CD-1 mice were cultured in Ca 2 þ -free Eagle's minimum essential medium supplemented with 8% Chelex-treated fetal bovine serum and induced to differentiate by elevating the Ca 2 þ concentration to 1 mM (D'Souza et al., 2001) . Keratinocytes were incubated in serum-free medium with virus for 5 h. The multiplicities of infection used for the viruses resulted in 90-100% efficiency, and were: PKCa, 10; wt PKCd, dnPKCd, wt and dn PKCe, and PKCz, 50; all other viruses, 75. These conditions ensured that X90% of cells were infected, and that expression of exogenous enzymes was six-to nine-fold greater than the corresponding endogenous enzyme, as measured by immunoblot. In keratinocytes, these levels of exogenous PKC expression result in three-to five-fold increases in PKC activity (Ohba et al., 1998; Luowei et al., 1999) . Incubations and final drug concentrations were: TPA, 100 nM, 24h; chelerythrine or Ro 317549, 1 mM; genistein, 300 mM, herbimycin A, 1 mM; and wortmannin, 50 nM; all added 3-4 h prior to adding 1 mM CaCl 2 . For E2F1 turnover experiments, cycloheximide (CHX; 100 mg/ml) was added 30 min prior to addition of TPA. In experiments using proteasomal inhibitors, primary keratinocytes were incubated with MG132 (10 mM, final) MG132 (10 mM, final), added to the culture medium 8 h following adjustment of Ca 2 þ to 1mm. The cells were cultured in high Ca 2 þ medium for 24 h prior to harvesting and lysate preparation. In these experiments, TPA was not used in conjunction with MG132 due to cytotoxicity of the drug combination over the incubation periods required. For p38 experiments, cells infected with adenovirus-encoding PKCd or PKCZ were immediately cultured in the presence of dimethylsulfoxide (DMSO) vehicle or 10 mM SB203580, SB202190 or SB202474. Fresh medium containing the inhibitor was added to the cells every 12 h.
Cell lysates and immunoblotting
Cell lysates were prepared and analyzed for EMSA or immunoblot as described (D'Souza et al., 2001 ). Fractions containing 50-100 mg protein were resolved by denaturing polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to polyvinylidene difluoride or nitrocellulose membranes. Immunoblots were probed with the appropriate antibodies. GAPDH or g-tubulin was used to normalize for protein loading. All results shown are representative of at least three experiments.
